ADMA Bio (ADMA) Company Long-Term Loans and Borrowings

ADMA Biologics Inc - graphic logo of issuer ADMA

The reliability of ADMA Biologics is based on FDA approval and the ownership of a network of plasma collection centers used to create high-demand immune preparations. The size of the issuer's long-term liabilities confirms its financial stability, with the value stabilizing at 0.20. Vertical integration of raw material flows minimizes supply risks, while full localization of production in the US offsets the impact of global trade conflicts.

ADMA ADMA Biologics: Company Long-Term Debts in the range 07/04/2022 - 10/28/2026

Analytical breakdowns for ADMA Bio (ADMA)

- price and consensus price forecast:
Stock Price admabiologics.com|ADMA - Price Target Chart
- market capitalization data:
Market Value ADMA Biologics|ADMA - Total Company Value
- book capitalization data:
Accounting Value per Share ADMA Biologics|ADMA - Book Capitalization|Market Capitalization to Book Value Ratio admabiologics.com|ADMA - Cumulative Company Assets
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio ADMA Biologics|ADMA - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient ADMA Corp|ADMA - Company Debts|Debt to Book Value ADMA Biologics|ADMA - Company Long-Term Debt|Company Current Liabilities ADMA Biologics
Fundamental company valuation:admabiologics.com (ADMA)
Original product of ADMA Biologics

The stable cash flow from plasma-derived product sales at ADMA Biologics (ADMA) allows the company to effectively service its obligations, as clearly reflected in the time series of its long-term debt. This indicator aggregates all credit obligations with maturities exceeding one year, enabling investors to assess financial stability and liquidity shortage risks when determining the asset's fair market value.

Competitor analysis for ADMA Biologics

argenx.com - Company Long-Term Debts|Company Long-Term Debt BioNTech (BNTX)|ABVX: Company Long-Term Loans and Borrowings|PTGX (Protagonist Therapeutics Inc) - Company Long-Term Debt|Immunovant Therapeutics (IMVT) - Company Long-Term Liabilities|KNSA (Kiniksa Pharmaceuticals) - Company Long-Term Debts|Company Long-Term Debts grifols.com (GRFS)|Adaptive Biotechnologies Corporation (ADPT) - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings Celldex Therapeutics Inc (CLDX)|Company Long-Term Debts AUPH|BioCryst Corp - Long-Term Debt Volume|VERA: Company Long-Term Debt|DNTH: Company Long-Term Liabilities|PHVS (Pharvaris) - Company Long-Term Debt|Company Long-Term Liabilities AbCellera Bio|TRML (Tourmaline Corp) - Company Long-Term Liabilities|Company Long-Term Debts PGEN|Company Long-Term Debt Pharming Group N.V. PHAR|Company Long-Term Indebtedness nektar.com (NKTR)|UPB: Company Long-Term Debts|Long-Term Debt Zenas Bio ZBIO|Immunome Corp - Company Long-Term Debts|GOSS - Company Long-Term Debts|Company Long-Term Debts KalVista Pharmaceuticals|SEPN (septerna.com) - Company Long-Term Indebtedness|Company Long-Term Debt PVLA|Company Long-Term Liabilities Savara Inc|Company Long-Term Debts RIGL|Company Long-Term Debts AnaptysBio Inc. ANAB|Company Long-Term Liabilities Astria Therapeutics|Company Long-Term Loans and Borrowings engene.com ENGN|RAPT - Company Long-Term Debts|JBIO - Company Long-Term Debt|Aclaris - Company Long-Term Debts|KYTX (Kyverna Therapeutics, Inc) - Long-Term Debt Volume|Company Long-Term Debt TLSA (Tiziana Life Sciences)|Long-Term Debt CABA|Company Long-Term Debt Ventyx Biosciences, Inc. (VTYX)|Company Long-Term Debt THTX (Theratechnologies, Inc.)|AVTX: Company Long-Term Debt|Long-Term Debt Eledon Pharmaceuticals, Inc ELDN|Company Long-Term Debts AGEN|CLYM - Long-Term Indebtedness|Zura Bio Limited - Company Long-Term Debts|aTyr Pharma Inc (ATYR) - Long-Term Debt Volume|Company Long-Term Debts ADAG|Company Long-Term Liabilities IMA|STTK (Shattuck Labs, Inc.) - Company Long-Term Debt|Long-Term Debt Volume equilliumbio.com (EQ)|Company Long-Term Debts CNTB (Connect Biopharma Holdings Limited)|Company Long-Term Debts Immunic Therapeutics IMUX|Atara Biotherapeutics Inc (ATRA) - Company Long-Term Debts|IFRX: Company Long-Term Indebtedness|XFOR (X4 Pharmaceuticals) - Company Long-Term Debt|Adicet Bio, Inc. (ACET) - Company Long-Term Liabilities|CELU (Celularity Inc) - Company Long-Term Debts|Company Long-Term Debts INMB|BRNS - Company Long-Term Debt|Long-Term Liabilities Kezar Life Sciences Inc (KZR)|Company Long-Term Debts SAB Biotherapeutics|Company Long-Term Loans and Borrowings akaritx.com AKTX|Enlivex Therapeutics, Ltd. - Company Long-Term Debts|QTTB: Company Long-Term Debts|Company Long-Term Debt GeoVax Labs Inc GOVX|EDSA (Edesa Biotech Corp) - Company Long-Term Loans and Borrowings|Company Long-Term Debt IBIO|Company Long-Term Liabilities Carisma Tx|Company Long-Term Debts XTLB|Company Long-Term Debts boltbio.com BOLT|Company Long-Term Liabilities HCW Biologics|Company Long-Term Loans and Borrowings Aptevo Therapeutics, Inc. APVO|Company Long-Term Debts AIM (AIM ImmunoTech)|ADTX: Long-Term Debt Volume|GRI (GRI Bio) - Company Long-Term Debt|XRTX (XORTX Therapeutics Inc) - Company Long-Term Liabilities|Company Long-Term Debt HIND|Company Long-Term Liabilities Revelation Biosciences Corp (REVB)|Company Long-Term Liabilities INDP|Company Long-Term Debts SCNI (scinai.com)|CALI - Company Long-Term Debt|Company Long-Term Indebtedness Affimed NV AFMD|ALLK (Allakos Therapeutics) - Company Long-Term Debts|HOOK - Long-Term Debt|IGMS: Company Long-Term Debts|iteostherapeutics.com (ITOS) - Company Long-Term Debts|Company Long-Term Debts Ocean Biomedical (OCEA)|Company Long-Term Indebtedness TCBP|Company Long-Term Debt THRD (Third Harmonic Bio, Inc)